Latest Diabetes: Drugs news
Once-Weekly Efsitora Noninferior to Degludec for Type 2 Diabetes
posted September 13th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM
posted August 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
GLP-1 Receptor Agonist Use Does Not Increase Insulin Discontinuation With Type 2 Diabetes 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Monthly Specialist Briefings
Stay Connected
